Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA3 | P07451 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.33 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8974686 | 0.89 | USP2 (0.39) | PAOX | |
| SCHEMBL2876932 | 0.87 | HSD17B10 (0.35) | TDP1 | |
| SCHEMBL20274401 | 0.83 | ALDH1A1 (0.39) | — | |
| SCHEMBL7729369 | 0.83 | CA12 (0.33) | CA12CA2CA3CA4CA6 | |
| SCHEMBL154162 | 0.80 | CA12 (0.46) | CA12CA2CA9TDP1 | |
| SCHEMBL22984189 | 0.80 | MAPT (0.33) | CA12CA2CA9MAPTTDP1 | |
| SCHEMBL275348 | 0.80 | MAPT (0.33) | CA12CA2CA9MAPTTDP1 | |
| SCHEMBL9639840 | 0.79 | CA12 (0.31) | CA12CA2CA3CA4CA6 | |
| SCHEMBL263104 | 0.79 | TDP1 (0.36) | TDP1EGFR | |
| SCHEMBL21608 | 0.79 | LMNA (0.40) | CA12CA2CA4CA9MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0604109-B1 | Suspension polymerization process for water-soluble monomers | ROHM & HAAS (US) | 1996-10-02 | — | — | EP | claimed |
| US-5498678-A | Suspension polymerization process for water-soluble monomers | ROHM AND HAAS COMPANY (US) | 1996-03-12 | — | — | US | claimed |
| EP-0604109-A2 | Suspension polymerization process for water-soluble monomers | ROHM AND HAAS COMPANY (US) | 1994-06-29 | — | — | EP | claimed |
| US-12227650-B2 | Method of preparing silicone-acrylate hybrid composition and hybrid composition formed thereby | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-02-18 | — | — | US | disclosed |
| CN-115252911-B | High-hydrophilicity medical catheter and preparation method thereof | 安徽省纳胜生物科技有限公司 | 2023-09-22 | — | — | CN | disclosed |
| US-20230042417-A1 | METHOD OF PREPARING SILICONE-ACRYLATE HYBRID COMPOSITION AND HYBRID COMPOSITION FORMED THEREBY | DOW GLOBAL TECHNOLOGIES LLC | 2023-02-09 | — | — | US | disclosed |
| EP-4085086-A1 | METHOD OF PREPARING SILICONE-ACRYLATE HYBRID COMPOSITION AND HYBRID COMPOSITION FORMED THEREBY | Dow Silicones Corporation (US) | 2022-11-09 | — | — | EP | disclosed |
| CN-115252911-A | High-hydrophilicity medical catheter and preparation method thereof | 安徽省纳胜生物科技有限公司 | 2022-11-01 | — | — | CN | disclosed |
| CN-115003715-A | Method for preparing silicone-acrylate hybrid compositions and hybrid compositions formed thereby | 美国陶氏有机硅公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2021138191-A1 | METHOD OF PREPARING SILICONE-ACRYLATE HYBRID COMPOSITION AND HYBRID COMPOSITION FORMED THEREBY | DOW SILICONES CORPORATION (US) | 2021-07-08 | — | — | WO | disclosed |
| US-10239963-B2 | Mixed salt suspension polymerization process and resins and catalysts produced thereof | ROHM AND HAAS COMPANY (US) | 2019-03-26 | — | — | US | disclosed |
| US-9012516-B2 | Copolymer, composition and method for modifying rheology | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-04-21 | — | — | US | disclosed |
| US-20150105487-A1 | MIXED SALT SUSPENSION POLYMERIZATION PROCESS AND RESINS AND CATALYSTS PRODUCED THEREOF | ROHM AND HAAS COMPANY (US) | 2015-04-16 | — | — | US | disclosed |
| EP-2859021-A1 | MIXED SALT SUSPENSION POLYMERIZATION PROCESS AND RESINS AND CATALYSTS PRODUCED THEREOF | Rohm and Haas Company (US) | 2015-04-15 | — | — | EP | disclosed |
| WO-2013188221-A1 | MIXED SALT SUSPENSION POLYMERIZATION PROCESS AND RESINS AND CATALYSTS PRODUCED THEREOF | ROHM AND HAAS COMPANY (US) | 2013-12-19 | — | — | WO | disclosed |
| US-20130296444-A1 | COPOLYMER, COMPOSITION AND METHOD FOR MODIFYING RHEOLOGY | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2013-11-07 | — | — | US | disclosed |
| EP-0604109-B1 | Suspension polymerization process for water-soluble monomers | ROHM & HAAS (US) | 1996-10-02 | — | — | EP | disclosed |
| US-5498678-A | Suspension polymerization process for water-soluble monomers | ROHM AND HAAS COMPANY (US) | 1996-03-12 | — | — | US | disclosed |
| US-4414374-A | IMPROVED GREEN STRENGTH | THE FIRESTONE TIRE & RUBBER COMPANY (US) | 1983-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130296444-A1 | COPOLYMER, COMPOSITION AND METHOD FOR MODIFYING RHEOLOGY | PAM, SELE, MSN | CA12 713/4885CA2 1396/4885CA3 2178/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.